(Q51612829)

8 April 2018

reason for preferred rank

title

Short-term Effects of Pamidronate on Biochemical Markers of Bone Metabolism in Osteoporosis—a Placebo-controlled Dose-finding Study (English)

1 reference

https://api.crossref.org/works/10.3109/03009739109179272

30 November 2022

Short-term effects of pamidronate on biochemical markers of bone metabolism in osteoporosis--a placebo-controlled dose-finding study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1810080

30 November 2022

0 references

1 reference

H. Mallmin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1810080

30 November 2022

S. Ljunghall

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1810080

30 November 2022

K. Larsson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1810080

30 November 2022

E. Lindh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1810080

30 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1810080

30 November 2022

publication date

1 January 1991

1 reference

8 April 2018

full work available at URL

http://www.tandfonline.com/doi/pdf/10.3109/03009739109179272

1 reference

https://api.crossref.org/works/10.3109/03009739109179272

Upsala Journal of Medical Sciences

30 November 2022

published in

1 reference

8 April 2018

volume

96

1 reference

8 April 2018

issue

3

1 reference

8 April 2018

page(s)

205-212

1 reference

8 April 2018

Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease

cites work

1 reference

https://api.crossref.org/works/10.3109%2F03009739109179272

The use of clodronate in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739109179272

Effects of ovariectomy in beagle dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739109179272

Skeletal responsiveness to parathyroid hormone in healthy females: relationship to menopause and oestrogen replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739109179272

Treatment of skeletal disease in breast cancer with clodronate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739109179272

Clodronate: the potential for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739109179272

Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009739109179272

21 January 2018

1

1

27

Boonenkamp P. M.

1986

1 reference

https://api.crossref.org/works/10.3109/03009739109179272

Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography

30 November 2022

5

1 reference

https://api.crossref.org/works/10.3109/03009739109179272

A one year follow-up study of the distribution of 14C-clodronate in mice and rats

30 November 2022

11

1 reference

https://api.crossref.org/works/10.3109/03009739109179272

30 November 2022

Clinical orthopaedics

12

174

193

Nagant de Deuxchainsnes C.

publication date

1983

1 reference

https://api.crossref.org/works/10.3109/03009739109179272

Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)

30 November 2022

16

1 reference

https://api.crossref.org/works/10.3109/03009739109179272

Pyrophosphate and diphosphonates in skeletal metabolism. Physiological, clinical and therapeutic aspects

30 November 2022

17

1 reference

https://api.crossref.org/works/10.3109/03009739109179272

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

30 November 2022

18

1 reference

https://api.crossref.org/works/10.3109/03009739109179272

Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD

30 November 2022

20

1 reference

https://api.crossref.org/works/10.3109/03009739109179272

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

30 November 2022

21

1 reference

https://api.crossref.org/works/10.3109/03009739109179272

30 November 2022

Identifiers

1 reference

8 April 2018

1 reference

8 April 2018